NEW YORK (GenomeWeb News) — A pan-European project created to discover biomarkers for monitoring and following patients with breast and colon cancer has received a €2.9 million ($3.9 million) grant from the European Union, project partner Ipsogen said today. 
The nine-member project, called Colon and Breast Cancer Diagnostics, or COBRED, is being coordinated by Paris-based Biosystems International, and the funding is being administered under the EU’s Sixth Framework Program.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.